Healthcare,
Life Sciences
& Pharma Translation
When your audience is a specialist, the language has to work as hard as the science. A clinician reading translated content is not just reading words. They are assessing whether the argument holds up and whether they trust the product behind it.
Healthcare and pharma translation for medical publishers, life sciences companies and pharma marketing teams.
A leave piece promoting a drug to specialists will be read by people who know the clinical evidence better than the copywriter who wrote it. A drug monograph translated with ambiguous dosage language creates a risk that no marketing team wants to carry. A medical journal article that loses its precision in translation loses its authority. The reader notices. In healthcare and life sciences, the cost of getting translation wrong is rarely just a reprint.
Most translation agencies can produce medically accurate copy. Fewer understand the difference between content written for a regulator and content written to persuade a specialist. That distinction matters. A leave piece needs to make an argument. A monograph needs to hold up to scrutiny. A pharma advert needs to move someone who has seen a hundred of them. Getting any of those wrong is not a translation failure. It is a commercial one.
Precise enough for a clinician.
Persuasive enough to sell.
When the reader knows more than the translator
Promotional content that persuades, not just informs
Transcreation when translation is not enough
Medical publishing that meets peer scrutiny
Consistency across documents that cannot afford errors
Confidentiality for commercially sensitive content
Pharma advertising that works in the target language
Deadlines that fit drug launch schedules
Healthcare and pharma translation across every content type.
From clinical journals to pharma advertising, each piece of healthcare content has a different job to do. The linguist needs to understand not just the subject but what the content is trying to achieve.
Healthcare and pharma
translation into all major markets.
Pharmaceutical and healthcare companies communicate across multiple markets simultaneously. A European drug launch may require translation into ten or more languages at the same time, with each version accurate, consistent and appropriate for the professional audience in that market.
We translate into all major pharmaceutical and healthcare markets, with native-speaking linguists selected for their medical and life sciences subject knowledge. Glossaries and translation memories travel across every language version to ensure consistency throughout.
Take a look at our
recent projects.
Insights for pharma and
healthcare communicators
Practical thinking on translation and transcreation for healthcare and life sciences, from people who work in it.
What healthcare and pharma
clients ask us about translation
Healthcare and pharma clients come to us with specific questions: do your linguists understand the therapy area? Can you handle transcreation as well as translation? What about confidentiality? We have answered the most common ones below.
Pre-launch data, clinical outcomes and competitive marketing materials are commercially sensitive. Every project is managed under NDA, with access restricted to the project team and files handled securely throughout. We are experienced in the confidentiality requirements of major pharmaceutical companies and apply those standards as a matter of course.
Translation transfers meaning accurately from one language to another. Transcreation goes further, adapting the creative concept, tone and persuasive approach so the content works in the target market rather than simply existing in it. Pharma marketing content often requires transcreation: a campaign that works in English may not carry the same clinical authority or emotional appeal in French or German without significant creative adaptation. We do both and advise which approach each project needs.
Yes. European and global drug launches routinely require simultaneous translation into multiple languages, each version consistent with the others and accurate for the professional audience in that market. We manage multilingual projects through a single account manager, with shared glossaries and translation memories ensuring consistency across every language version.
Regulatory and clinical trial translation is a highly specialised discipline with its own compliance requirements and quality standards. It is not our area of focus. Our expertise is in pharma marketing, medical publishing and life sciences communications content for professional audiences. If regulatory translation is what you need, we can point you towards specialists in that area.
Yes. Drug monographs and clinical white papers are among the most technically demanding documents we handle. Length, density and the need for absolute consistency throughout make them a significant project management challenge as well as a linguistic one. We build a comprehensive glossary before translation begins and apply it across the entire document, including any future updates or revisions.
Yes. Promotional content for HCP audiences is one of our core areas of work. Leave pieces, detail aids, congress materials and medical education content for professional audiences all require a linguist who understands both the clinical subject and the promotional context. We have worked on HCP-facing content for clients including Bayer and GE Healthcare.
Yes. We select linguists for healthcare and pharma projects on the basis of subject knowledge as well as language skills. A linguist translating a cardiology leave piece needs to understand the clinical argument, not just the terminology. We match every project to a linguist whose background fits the therapy area and the type of content involved.